Serina Therapeutics, Inc. SEC filings SER
Serina Therapeutics, Inc. has 519 filings in SEC EDGAR's recent list, going back to Jul 10, 2017. Its latest annual report, Form 10-K, was filed on Mar 25, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 9, 2026 (bylaw or fiscal year change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Apr 28, 2026 | — |
| DEF 14A | Proxy statement | Apr 27, 2026 | Apr 27, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 17, 2026 | Apr 17, 2026 |
| DEFA14A | Additional proxy material | Sep 26, 2025 | — |
| DEF 14A | Proxy statement | Sep 26, 2025 | Sep 26, 2025 |
| PRE 14A | Preliminary proxy statement | Sep 15, 2025 | Sep 15, 2025 |
| DEFA14A | Additional proxy material | Nov 6, 2024 | — |
| DEF 14A | Proxy statement | Nov 6, 2024 | Dec 13, 2024 |
| DEF 14A | Proxy statement | Nov 14, 2023 | Nov 14, 2023 |
| DEFA14A | Additional proxy material | Nov 7, 2023 | — |
| DEF 14A | Proxy statement | Nov 7, 2023 | Nov 7, 2023 |
| PRE 14A | Preliminary proxy statement | Sep 22, 2023 | Sep 22, 2023 |
| DEFA14A | Additional proxy material | Nov 2, 2022 | — |
| DEF 14A | Proxy statement | Nov 2, 2022 | Nov 2, 2022 |
| PRE 14A | Preliminary proxy statement | Sep 16, 2022 | Sep 16, 2022 |
| DEFA14A | Additional proxy material | Nov 24, 2021 | — |
| DEF 14A | Proxy statement | Nov 24, 2021 | Nov 24, 2021 |
| DEFA14A | Additional proxy material | Dec 22, 2020 | — |
| DEFA14A | Additional proxy material | Nov 24, 2020 | — |
| DEF 14A | Proxy statement | Nov 24, 2020 | Nov 24, 2020 |
| PRE 14A | Preliminary proxy statement | Nov 5, 2020 | Nov 5, 2020 |
| DEFA14A | Additional proxy material | Dec 3, 2019 | — |
| DEF 14A | Proxy statement | Nov 29, 2019 | Nov 29, 2019 |
Showing 23 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SER (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- AL
- Headquarters
- Huntsville, AL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1708599
- Former names
- AgeX Therapeutics, Inc. (until Apr 1, 2024)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.